Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Activation of hepatic stellate cells (HSCs) and their trans-differentiation towards collagen-secreting myofibroblasts (MFB) promote liver fibrosis progression. During chronic liver disease, resting HSCs become activated by inflammatory and injury signals. However, HSCs/MFB not only produce collagen, but also secrete cytokines, participate in metabolism, and have biomechanical properties. We herein aimed to characterize the heterogeneity of these liver mesenchymal cells by single cell RNA sequencing. In vivo resting HSCs or activated MFB were isolated from C57BL6/J mice challenged by carbon tetrachloride (CCl4) intraperitoneally for 3 weeks to induce liver fibrosis and compared to in vitro cultivated MFB. While resting HSCs formed a homogenous population characterized by high platelet derived growth factor receptor β (PDGFRβ) expression, in vivo and in vitro activated MFB split into heterogeneous populations, characterized by α-smooth muscle actin (α-SMA), collagens, or immunological markers. S100 calcium binding protein A6 (S100A6) was a universal marker of activated MFB on both the gene and protein expression level. Compared to the heterogeneity of in vivo MFB, MFB in vitro sequentially and only transiently expressed marker genes, such as chemokines, during culture activation. Taken together, our data demonstrate the heterogeneity of HSCs and MFB, indicating the existence of functionally relevant subsets in hepatic fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ScRNA-seq allows for high-resolution transcriptomic profiling of mesenchymal subpopulations during liver fibrosis, revealing that chemokine/cytokine release and extracellular matrix production are diversified among HSC/myofibroblast subpopulations owing to a higher degree of cellular heterogeneity than previously appreciated.109–111”
From An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023) · cites this paper as [110]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Fcna (a marker of quiescent hepatic stellate cells 53 )”
From Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis (2024) · cites this paper as [53]
In the citing paper
“scRNAseq data from mouse fibrosis models revealed that chemokine/cytokine release and ECM production appears to be diversified between HSC/myofibroblast subpopulations.130”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [130]
In the citing paper
“Unbiased cross-species mapping of scRNAseq data using canonical correlation analysis (CCA)21 confirmed that murine and human scar-associated macrophages represent corollary populations.”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909 · cited 1×
“Upregulated expression of chemokines, such as CCL2, CXCL1, or CXCL12, and collagens, particularly COL1A2, COL3A1, or COL5A2, are often named attributes for activated MFB [13].”
Dulai, P. S., Singh, S., Patel, J., Soni, M., Prokop, L. J., Younossi, Z., Sebastiani, G., Ekstedt, M., Hagstrom, H., Nasr, P., et al. (2017) · Hepatology · doi:10.1002/hep.29085 · Cited by 1,965 · cited 1×
“Liver fibrosis is also considered as a cornerstone event in the progression toward liver cirrhosis or hepatocellular carcinoma [15].”
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations
MacParland, S. A., Liu, J. C., Ma, X.-Z., Innes, B. T., Bartczak, A. M., Gage, B. K., Manuel, J., Khuu, N., Echeverri, J., Linares, I., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06318-7 · Cited by 1,552
Hepatic stellate cells as key target in liver fibrosis
Higashi, T., Friedman, S. L., & Hoshida, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.007 · Cited by 1,485 · cited 1×
“Preventing or reversing excessive hepatic scarring is a major therapeutic target in treating chronic liver diseases, such as viral hepatitis and alcoholic and non-alcoholic steatohepatitis [2].”
Pathobiology of liver fibrosis: a translational success story
Lee, Y. A., Wallace, M. C., & Friedman, S. L. (2015) · Gut · doi:10.1136/gutjnl-2014-306842 · Cited by 894 · cited 1×
“The upregulation of collagens and α-SMA in MFB is a well-established finding [16] and was confirmed by our single-cell based data for MFB in vivo as well as in vitro.”
Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications
Weiskirchen, R., Weiskirchen, S., & Tacke, F. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.06.003 · Cited by 538 · cited 1×
“At present, α-SMA is largely accepted as a marker of activated MFB [12].”
Self-citationInflammatory macrophages can transdifferentiate into myofibroblasts during renal fibrosis
Meng, X.-M., Wang, S., Huang, X.-R., Yang, C., Xiao, J., Zhang, Y., To, K.-F., Nikolic-Paterson, D. J., & Lan, H.-Y. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.402 · Cited by 325 · cited 2×
“Due to the combination of characteristics of myeloid leukocytes, as well as of myofibroblasts, cluster MFB II most likely includes trans-differentiated myeloid myofibroblasts, which have been described before [11].”
Weiskirchen, R., & Tacke, F. (2014) · PubMed · doi:10.3978/j.issn.2304-3881.2014.11.03 · Cited by 256 · cited 3×
“, contraction and vascular resistance regulation in the liver), and lipid metabolism to immune regulation [4], raising the question about yet unrecognized, functionally diverse subsets of HSCs/MFB.”
Self-citation
Cited by
Items 201–253 of 253
The Role of Neutrophil, Monocyte and Macrophage Calprotectin and S100A12 in the Fibrotic Process
Regino-Zamarripa, N. E., Burciaga, A. S., Bocanegra-Mondragón, M., Cruz‐Lagunas, A., Camarena, Á., Jiménez-Álvarez, L. A., Ramírez, R., Ramírez-Martínez, G., & Zúñiga, J. (2026) · Biomolecules · doi:10.3390/biom16040553 · Cited by 1
“High S100A6 mRNA and proteins levels have been documented in IPF [138], myocardial infraction [139], liver cirrhosis [140], renal fibrosis [141], and neurodegenerative diseases, such as Alzheimer’s disease [142].”
Epigenetic reprogramming of hepatic antigen presenting cells in chronic liver disease
Ángel‐Gomis, E., Juanola, O., Caparrós, E., & Francés, R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1783588 · Cited by 1
Feng, X., Feng, Y., Raza, S. H. A., Ma, Y. P., & Deng, H. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2026.1781941 · Cited by 1
“…cellular atlases (Aizarani et al., 2019), delineate developmental trajectories (Dobie et al., 2019; Daemen et al., 2021; Xiong et al., 2019; Krenkel et al., 2019; Krenkel et al., 2020; Seidman et al., 2020), and elucidate the pathogenesis of diverse liver diseases including NAFLD…”
Equal opportunity offer for all hepatocytes
Dai, Z., Ott, M., & Sharma, A. D. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.038 · Cited by 1
Meng, Z., Zhou, T., Gou, J., Jiang, C., Li, B., Zhou, H., Liu, J., Feng, Q., & Wen, L. (2025) · Research Square · doi:10.21203/rs.3.rs-7551051/v1 · Cited by 1
Wang, J., Tao, J., Xia, C., Tang, M., Stoica, A.-F., Yuan, S., Li, Y., Guo, L., Kong, X., & Wang, J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.25.690307 · Cited by 1
Single-Cell Profiling of Paracrine Network and Immune Landscape in Non-Alcoholic Steatohepatitis
Kuang, H. (2020) · Deep Blue (University of Michigan) · doi:10.7302/4751
Zhang, S., Liu, Y., Chen, L., Liu, Y., Guo, Y., Cheng, J., & Huang, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.22.543838
Promoting Liver Regeneration by Utilizing Liver Macrophage Metabolism
刘, 云. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.141049
Drasdo, D., Zhao, J., Hammad, S., de Langlard, M., Erdoesi, P., Li, Y., Liedekerke, P. V., Buttenschön, A., Winkler, M., Kürschner, S. W., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3911195/v1
Les fibulines, de nouveaux acteurs dans les maladies chroniques hépatiques
Thomas, C. (2024) · theses.fr (ABES) · doi:10.70675/5ecd5f64zca9ez4ce8zbf8dz62e4fa112860
Copple, B. L., & Poole, L. G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00240-0
Pathomechanismen der hepatischen Fibrogenese
Horn, P., & Tacke, F. (2025) · Springer eBooks · doi:10.1007/978-3-662-70167-6_1
Self-citationWang, H., Zheng, S., Jiang, H., Wang, X., Zhou, F., & Weng, Z. (2022) · Figshare · doi:10.6084/m9.figshare.19092639
Johnson, N. D., Wu, X., Still, C. D., Chu, X., Petrick, A. T., Gerhard, G. S., Conneely, K. N., & DiStefano, J. K. (2021) · Figshare · doi:10.6084/m9.figshare.15122268
Wang, H., Zheng, S., Jiang, H., Wang, X., Zhou, F., & 翁志宏 (2022) · Figshare · doi:10.6084/m9.figshare.19092636
Puengel, T. (2023) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-39885
Wang, H., Zheng, S., Jiang, H., Wang, X., Zhou, F., & 翁志宏 (2022) · Figshare · doi:10.6084/m9.figshare.19092627
Wang, H., Zheng, S., Jiang, H., Wang, X., Zhou, F., & 翁志宏 (2022) · Figshare · doi:10.6084/m9.figshare.19092624
Wang, H., Zheng, S., Jiang, H., Wang, X., Zhou, F., & 翁志宏 (2022) · Figshare · doi:10.6084/m9.figshare.19092618
Mechanistic Elucidation of the Function of Sirtuin 6 in the Regulation of Liver Fibrosis
Chowdhury, K. (2022) · IUScholarWorks (Indiana University) · doi:10.7912/c2/3065
Wang, H., Zheng, S., Jiang, H., Wang, X., Zhou, F., & 翁志宏 (2022) · Figshare · doi:10.6084/m9.figshare.19092630
Wang, H., Zheng, S., Jiang, H., Wang, X., Zhou, F., & 翁志宏 (2022) · Figshare · doi:10.6084/m9.figshare.19092633
Wang, G. (2025) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00035970
Role of WNT1-inducible signaling pathway protein-1 (WISP1) in liver injury
Leiva, D. F. G. (2020) · Technische Universität Dortmund Eldorado (Technische Universität Dortmund) · doi:10.17877/de290r-21916
Xie, Q., Liu, R., Jiang, J., Peng, J., Yang, C., Zhang, W., Wang, S., & Song, J. (2020) · Figshare · doi:10.6084/m9.figshare.13316930
Wang, H., Zheng, S., Jiang, H., Wang, X., Zhou, F., & 翁志宏 (2022) · Figshare · doi:10.6084/m9.figshare.19092621
Study of the effects of PPAR-β/δ activators in the treatment of MASH
Zhang, M. (2024) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Sehgal, R., Gautam, P., Islam, M., Sevak, J. K., Javed, M., Kaur, N., Ramakrishna, G., Maiwall, R., Sarin, S. K., & Trehanpati, N. (2025) · Scientific Reports · doi:10.1038/s41598-025-89084-z
“Single-cell transcriptomics sequencing has lately expanded rapidly due to its broad application across multiple domains since it delivers an accurate depiction of every cell type and its associated gene expression patterns 21–23 .”
Kessler, A., Chen, Y., Biswas, S., & Feldman, D. E. (2025) · doi:10.61440/jmdr.2025.v2.09
Zhang, X., Cheng, Y., Yu, R., Hu, X., & Huang, Y. (2026) · PLoS ONE · doi:10.1371/journal.pone.0332881
Lin, H., Jia, B., Chang, B., Sun, F., Tan, Y., Tian, Y., Fan, Y., Liang, J., & Wu, A. W. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c15968
Identification of portal mesenchymal stem cells and derived myofibroblasts in liver fibrosis
Lei, L. (2020) · theses.fr (ABES) · doi:10.70675/3f63c15ezc769z48acz89d2z46ba95102826
Role of the protein ADAMTS12 in the progression of Chronic Liver Diseases
Azar, F. (2021) · theses.fr (ABES) · doi:10.70675/df5a3af0ze005z4d00z982fz020900d13f4e
La nécroptose : une nouvelle cible thérapeutique dans la stéatohépatite non-alcoolique
Majdi, A. (2020) · theses.fr (ABES) · doi:10.70675/94f28bbaz6c2dz4b48zb1aaze6b48ca72708
Role of Gli1+ cells in chronic liver diseases
Raposo, M. A. (2024) · theses.fr (ABES) · doi:10.70675/a0379d76z79c0z4341zba7bz0abd8648eed2
Impact de l'élongase ELOVL5 sur la stéatose et l'inflammation au niveau hépatique
Vouilloz, A. (2023) · theses.fr (ABES) · doi:10.70675/6eb3b3cez17d4z4977z95b3z2a094b6ece36
贺, 铜., Zhang, Y. J., Pan, H., Wang, S., Zhao, Y., Zhao, Z., Bao, Y., & Wang, L. (2026) · Inflammation · doi:10.1007/s10753-026-02524-4
“Oliver et al. reported that S100A6 is a universal marker of activated collagen-secreting myo-fibroblasts (MFB) at both the gene and protein expression levels [ 30 ].”
ScopeViewer: a browser-based solution for visualizing large biological images
Luo, D., Robertson, S., Zhan, Y., Rong, R., Wang, S., Jiang, X., Yang, S., Palmer, S. N., Quan, P., Kanzaki, H., et al. (2026) · GigaScience · doi:10.1093/gigascience/giag074
Jiang, W., Wei, W., Tu, S., Yan, J., & Yan, X. (2026) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2026138
Mi, J., Su, K., Wang, R., Zhou, J., Yan, F., & Liu, O. (2026) · Drug Discovery Today · doi:10.1016/j.drudis.2026.104753
Weninger, J., Lee, A. L., Marek, G. W., Lange, N. F., Mauer, A. S., Puri, G., Shah, V. H., & Malhi, H. (2026) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00223.2026
Foglia, B., Nurcis, J., Signorini, M., Novo, E., Bocca, C., Cannito, S., & Parola, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188213
“All these critical processes are known to be deeply involved in the progression of CLDs of different etiologies toward more advanced pathological stages, including cirrhosis and liver failure as well as HCC development [41,53,54,56,57].”
Meng, Z., Chen, Z., Zhou, T., Gou, J., Ma, Z., Yue, A., Jiang, C., Feng, Q., & Wen, L. (2026) · Mediators of Inflammation · doi:10.1155/mi/1367877
Chen, R., Yang, Y., Chen, G., Cai, X., Lu, L., & Ge, Q. (2026) · Journal of Translational Gastroenterology · doi:10.14218/jtg.2026.00026
Lu, W., Xu, J., Wang, K., Chen, Y., Cherubini, A., Valenti, L. V. C., Zheng, S., & Liu, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1954491
Zhan, T., Wu, Y., Deng, X., Li, Q., Chen, Y., Lv, J., Wang, J., Li, S., Wu, Z., Liu, D., et al. (2023) · doi:10.3389/fcimb.2023.1286977.s001
Hajiabadi, S., Alidadi, S., Farahi, Z. M., Seno, M. M. G., Farzin, H., & Haghparast, A. (2023) · doi:10.3389/fimmu.2023.1258691.s002
Metadata
- Authors
- Krenkel, O., Hundertmark, J., Ritz, T., Weiskirchen, R., & Tacke, F.
- Affiliations
- Boehringer Ingelheim (Germany) (DE)
- Universitätsklinikum Aachen (DE)
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- Tacke, Frank
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-05-24
- Volume
- 8
- Issue
- 5
- Pages
- 503
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC6562512
- OpenAlex
- W2945705065
- Cited by
- 241
- References
- 20
- Citations by year
- 2026: 19 · 2025: 41 · 2024: 23 · 2023: 40 · 2022: 38 · 2021: 37 · 2020: 33 · 2019: 10
- FWCI
- 18.80
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Deutsche Forschungsgemeinschaft (SFB/TRR57, Ta434/3-1, Ta434/5-1)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- hepatic stellate cells, myofibroblasts, liver fibrosis, cellular heterogeneity, hepatic stellate cell activation, transdifferentiation, S100A6, PDGFRβ, alpha-smooth muscle actin, collagen, carbon tetrachloride, chemokines, single-cell RNA sequencing
- MeSH terms
- S100 Calcium Binding Protein A6, Actins, Animals, Base Sequence, Carbon Tetrachloride, Cells, Cultured, Collagen, Disease Models, Animal, Liver, Liver Cirrhosis, Mice, Inbred C57BL, Gene Expression, Sequence Analysis, RNA, Genetic Heterogeneity, Cell Cycle Proteins, Chemokines, Receptor, Platelet-Derived Growth Factor beta, Mice, Hepatic Stellate Cells, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.